Zambon’s Hopledo wins CHMP backing, but can fewer daily doses reshape Parkinson’s care?
See how Zambon’s Hopledo could change Parkinson’s motor fluctuation care in Europe after a positive CHMP opinion, and what risks remain.
Pharma & Biotech
Pharma & Biotech
Can Evecxia Therapeutics turn EVX-101 into the first serotonin synthesis amplification therapy?
EVX-101 revives serotonin synthesis as an SSRI add-on strategy. Can Evecxia prove old biology still has new clinical value?